Design Therapeutics Correlations
DSGN Stock | USD 5.97 0.18 2.93% |
The current 90-days correlation between Design Therapeutics and Monte Rosa Therapeutics is 0.12 (i.e., Average diversification). A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Design Therapeutics moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Design Therapeutics moves in either direction, the perfectly negatively correlated security will move in the opposite direction.
Design Therapeutics Correlation With Market
Weak diversification
The correlation between Design Therapeutics and DJI is 0.34 (i.e., Weak diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Design Therapeutics and DJI in the same portfolio, assuming nothing else is changed.
Design |
Moving together with Design Stock
0.62 | NAMS | NewAmsterdam Pharma | PairCorr |
0.71 | AGIO | Agios Pharm | PairCorr |
0.65 | SGMO | Sangamo Therapeutics Buyout Trend | PairCorr |
0.61 | CRVS | Corvus Pharmaceuticals | PairCorr |
Moving against Design Stock
0.59 | PEPG | PepGen | PairCorr |
0.5 | MRK | Merck Company Fiscal Year End 6th of February 2025 | PairCorr |
0.46 | JNJ | Johnson Johnson Fiscal Year End 28th of January 2025 | PairCorr |
0.38 | NKTX | Nkarta Inc Buyout Trend | PairCorr |
0.37 | FDMT | 4D Molecular Therapeutics | PairCorr |
0.37 | PDSB | PDS Biotechnology Corp | PairCorr |
0.35 | MREO | Mereo BioPharma Group | PairCorr |
0.34 | PIRS | Pieris Pharmaceuticals | PairCorr |
0.54 | COLL | Collegium Pharmaceutical | PairCorr |
0.48 | ADAP | Adaptimmune Therapeutics | PairCorr |
0.4 | BDTX | Black Diamond Therap | PairCorr |
Related Correlations Analysis
Click cells to compare fundamentals | Check Volatility | Backtest Portfolio |
Correlation Matchups
Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between Design Stock performing well and Design Therapeutics Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Design Therapeutics' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
---|---|---|---|---|---|---|---|---|---|---|
GLUE | 4.99 | 0.61 | 0.18 | 0.32 | 3.86 | 7.42 | 102.66 | |||
HOWL | 4.64 | (0.23) | (0.02) | 0.01 | 4.47 | 8.54 | 49.02 | |||
IKNA | 0.90 | (0.11) | 0.00 | (0.09) | 0.00 | 1.80 | 5.87 | |||
STOK | 2.61 | (0.33) | 0.00 | (0.13) | 0.00 | 4.68 | 21.35 | |||
ACHL | 2.02 | 0.60 | 0.20 | 5.49 | 1.53 | 3.06 | 38.16 | |||
NLTX | 2.25 | (0.07) | 0.00 | 0.19 | 0.00 | 4.05 | 27.84 | |||
MGTA | 2.62 | 0.06 | 0.00 | 0.26 | 3.40 | 5.88 | 16.99 | |||
GRPH | 2.36 | (0.13) | 0.00 | (0.39) | 0.00 | 4.79 | 14.40 | |||
ALXO | 3.43 | (0.91) | 0.00 | (0.31) | 0.00 | 6.94 | 22.71 | |||
AADI | 2.00 | 0.34 | 0.14 | 0.39 | 2.07 | 4.88 | 13.95 |
Design Therapeutics Corporate Management
Aseem Ansari | CoFounder Advisor | Profile | |
Sean Jeffries | Chief Officer | Profile | |
Elizabeth Gordon | Senior Affairs | Profile | |
Mustapha Parekh | General Counsel | Profile | |
Joo MD | CEO Pres | Profile | |
MD FACC | Consulting Officer | Profile |